Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Pharmaids Pharmaceuticals is engaged in the manufacturing of ayurvedic medicines and trading of allopathic medicines.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024. | Download
PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024. | Download
PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06, 2025 | Download
PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06, 2025 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant